Emerging information suggests a compelling possibility for a synergistic interaction between Alluvian and Retatrutide, representing a groundbreaking therapeutic strategy for several metabolic diseases. Preliminary studies indicate that combining these two agents may yield improved efficacy compared to either alone, potentially targeting a wider spe